1. Home
  2. GOVX vs GYRO Comparison

GOVX vs GYRO Comparison

Compare GOVX & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOVX
  • GYRO
  • Stock Information
  • Founded
  • GOVX 2001
  • GYRO 1946
  • Country
  • GOVX United States
  • GYRO United States
  • Employees
  • GOVX N/A
  • GYRO N/A
  • Industry
  • GOVX Biotechnology: Pharmaceutical Preparations
  • GYRO Building operators
  • Sector
  • GOVX Health Care
  • GYRO Real Estate
  • Exchange
  • GOVX Nasdaq
  • GYRO Nasdaq
  • Market Cap
  • GOVX 19.5M
  • GYRO 20.4M
  • IPO Year
  • GOVX N/A
  • GYRO N/A
  • Fundamental
  • Price
  • GOVX $1.67
  • GYRO $8.90
  • Analyst Decision
  • GOVX Strong Buy
  • GYRO
  • Analyst Count
  • GOVX 5
  • GYRO 0
  • Target Price
  • GOVX $14.20
  • GYRO N/A
  • AVG Volume (30 Days)
  • GOVX 569.4K
  • GYRO 484.0
  • Earning Date
  • GOVX 03-03-2025
  • GYRO 01-01-0001
  • Dividend Yield
  • GOVX N/A
  • GYRO N/A
  • EPS Growth
  • GOVX N/A
  • GYRO N/A
  • EPS
  • GOVX N/A
  • GYRO N/A
  • Revenue
  • GOVX $3,090,161.00
  • GYRO $2,738,019.00
  • Revenue This Year
  • GOVX N/A
  • GYRO N/A
  • Revenue Next Year
  • GOVX $150.51
  • GYRO N/A
  • P/E Ratio
  • GOVX N/A
  • GYRO N/A
  • Revenue Growth
  • GOVX N/A
  • GYRO N/A
  • 52 Week Low
  • GOVX $1.09
  • GYRO $7.65
  • 52 Week High
  • GOVX $11.18
  • GYRO $11.96
  • Technical
  • Relative Strength Index (RSI)
  • GOVX 37.32
  • GYRO 39.74
  • Support Level
  • GOVX $1.50
  • GYRO $8.90
  • Resistance Level
  • GOVX $1.79
  • GYRO $9.50
  • Average True Range (ATR)
  • GOVX 0.13
  • GYRO 0.05
  • MACD
  • GOVX 0.01
  • GYRO -0.02
  • Stochastic Oscillator
  • GOVX 29.82
  • GYRO 19.64

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.

About GYRO Gyrodyne LLC

Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.

Share on Social Networks: